Related Experiment Video
Updated: May 8, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Hepatitis B virus-induced hepatocellular carcinoma
Cheng Xu1, Wence Zhou2, Yuming Wang1
1Institute for Infectious Diseases, Southwest Hospital, Third Military Medical University, Chongqing 400038, China.
Hepatitis B virus (HBV) can cause liver cancer (HCC) through viral products, DNA integration, and host factors. HBx protein and epigenetic changes are key contributors to HBV-induced HCC development.
Area of Science:
- Hepatology
- Oncology
- Virology
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern.
- Hepatitis B virus (HBV) infection is a primary driver of HCC.
- Understanding HBV's role in HCC pathogenesis is crucial.
Purpose of the Study:
- To review recent advancements in understanding HBV-induced HCC.
- To highlight key viral and host factors contributing to liver cancer.
- To provide an overview of current research on HBV and HCC.
Main Methods:
- Literature review of recent studies on HBV-associated HCC.
- Analysis of factors including HBV products, integration, mutations, and host susceptibility.
- Examination of the role of HBx protein and epigenetic modifications.
Main Results:
- HBV X protein (HBx) impacts cell proliferation and apoptosis pathways.
- Recurrent HBV DNA integration sites found in hepatoma cells.
- Host genetic factors, epigenetic changes, and inflammation contribute to liver cancer.
Conclusions:
- Multiple factors contribute to HBV-induced HCC.
- HBx protein, HBV DNA integration, and host susceptibility are critical.
- Ongoing research continues to elucidate the complex mechanisms of liver cancer development.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction

